Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

China Authorities: GSK Executives Admit to Bribing Scheme

publication date: Jul 11, 2013
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
GlaxoSmithKline executives in China have reportedly confessed to bribing government officials, hospitals and doctors, a scheme that has been in place for “years.” The executives used travel agencies to make and conceal the transactions. With faked invoices from the travel agencies, GSK effectively avoiding paying taxes on the bribes, according to China’s Ministry of Public Safety, which released the first details of the two-week-old scandal on its website. More details....

Stock Symbol: (NYSE: GSK)

Share this with colleagues:  

This article is available for purchase - please click here for details.

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...